Jacob Bor
Profiles

Jacob Bor, SD

Associate Professor, Global Health - Boston University School of Public Health

617-358-2176
jbor@bu.edu
Crosstown Center
View Full Profile at BUMC

Biography

Jacob Bor, ScD, is an Associate Professor in the Departments of Global Health and Epidemiology at Boston University School of Public Health. His research applies the analytical tools of economics and data science to the study of population health. Research interests include HIV treatment and prevention in southern Africa, structural causes of health disparities in the U.S, and intersections of health, politics, and development. Prior to his graduate training at Harvard School of Public Health, Dr. Bor worked with an HIV-prevention NGO in Botswana, Lesotho, and South Africa. He is a faculty affiliate of BU's Global Development Policy Center and Senior Research at the Health Economics and Epidemiology Research Office (www.heroza.org) in South Africa.

Other Positions

  • Associate Professor, Epidemiology - Boston University School of Public Health

Education

  • Harvard School of Public Health, SD Field of Study: Global Health Management
  • Harvard School of Public Health, SM/ScM Field of Study: Economics
  • Harvard College, AB Field of Study: Social Sciences

Websites

Classes Taught

  • SPHPH720

Publications

  • Published on 12/1/2025

    Dzomba A, Shumba K, Nattey C, Lauren E, Brennan AT, McLoed W, Fox MP, Bor J, Onoya D. HIV Patient Treatment Adherence Trajectories in First 24 months After ART Initiation Among Adults: An Electronic Health Records Cohort From South Africa. J Acquir Immune Defic Syndr. 2025 Dec 01; 100(4):305-314. PMID: 40778758.

     Read At: PubMed
  • Published on 9/22/2025

    Zheng A, Brennan AT, Greener R, Kileel EM, Bor J, Venter WDF, Murray EJ, Pisa PT, Goeieman B, Fox MP, Maskew M. Initiation of dolutegravir vs. efavirenz on 12- and 24-month retention and viral suppression: a target trial emulation. Infect Dis (Lond). 2025 Sep 22; 1-11. PMID: 40982349.

     Read At: PubMed
  • Published on 9/8/2025

    Lauren E, Shumba K, Fox MP, MacLeod W, Stevens W, Mlisana K, Bor J, Onoya D. Correction: The fall-And rise-In hospital-based care for people with HIV in South Africa: 2004-2017. PLOS Glob Public Health. 2025; 5(9):e0005169. PMID: 40920701.

     Read At: PubMed
  • Published on 7/15/2025

    Bor J, Bird M, Hakes JK, Himmelstein DU, Himmelstein G, Woolhandler S. Life Expectancy of American Indian and Alaska Native Persons and Underreporting of Mortality in Vital Statistics. JAMA. 2025 Jul 15; 334(3):243-252. PMID: 40522635.

     Read At: PubMed
  • Published on 7/9/2025

    Shumba K, Bor J, Nattey C, Gareta D, Lauren E, Macleod W, Fox MP, Puren A, Mlisana K, Onoya D. Record linkage without patient identifiers: Proof of concept using data from South Africa's national HIV program. PLOS Glob Public Health. 2025; 5(7):e0004835. PMID: 40632720.

     Read At: PubMed
  • Published on 6/1/2025

    Zheng A, Fox MP, Greener R, Kileel EM, Bor J, Venter WDF, Pisa PT, Brennan AT, Maskew M. Initiation of Dolutegravir Versus Efavirenz on Viral Suppression and Retention at 6 months: A Regression Discontinuity Design. J Acquir Immune Defic Syndr. 2025 Jun 01; 99(2):151-157. PMID: 39913899.

     Read At: PubMed
  • Published on 5/2/2025

    Bor J, Raquib RV, Wrigley-Field E, Woolhandler S, Himmelstein DU, Stokes AC. Excess US Deaths Before, During, and After the COVID-19 Pandemic. JAMA Health Forum. 2025 May 02; 6(5):e251118. PMID: 40408091.

     Read At: PubMed
  • Published on 4/30/2025

    Nichols BE, Dodge JL, Lee BP, Bhadelia N, Bor J. Medicaid cuts, mortality, and health-care expenditure in the USA. Lancet. 2025 May 17; 405(10491):1736. PMID: 40318689.

     Read At: PubMed
  • Published on 4/25/2025

    Hontelez JAC, Goymann H, Berhane Y, Bhattacharjee P, Bor J, Chabata ST, Cowan F, Kimani J, Knox J, Lora WS, Lungu C, Manne-Goehler J, Mauti J, Moshabela M, Mpembeni RM, Wa Mwanza M, Ndung'u T, Omondi E, Phiri S, Siedner M, Tanser FC, de Vlas SJ, Bärnighausen TW. The impact of the PEPFAR funding freeze on HIV deaths and infections: a mathematical modelling study of seven countries in sub-Saharan Africa. EClinicalMedicine. 2025 May; 83:103233. PMID: 40626258.

     Read At: PubMed
  • Published on 3/12/2025

    Shapiro AN, Moultrie H, Jacobson KR, Bor J, da Silva P, Scott L, Jenkins HE. The risk of rifampicin-resistant TB after drug-susceptible TB treatment. IJTLD Open. 2025 Mar; 2(3):173-175. PMID: 40092522.

     Read At: PubMed

View 126 more publications:View Full Profile at BUMC

News & In the Media

View all profiles